{"id":797,"date":"2021-01-28T11:45:30","date_gmt":"2021-01-28T11:45:30","guid":{"rendered":"https:\/\/nclinnovations.org\/covid19monitor\/?p=797"},"modified":"2021-01-28T11:45:30","modified_gmt":"2021-01-28T11:45:30","slug":"26-jan-2021-favipiravir-decreases-the-hospital-stay-and-the-need-for-mechanical-ventilation","status":"publish","type":"post","link":"https:\/\/nclinnovations.org\/covid19monitor\/26-jan-2021-favipiravir-decreases-the-hospital-stay-and-the-need-for-mechanical-ventilation\/","title":{"rendered":"(26 Jan 2021) Favipiravir- decreases the hospital stay and the need for mechanical ventilation"},"content":{"rendered":"<div class=\"boldgrid-section\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-12 col-xs-12 col-sm-12\">\n<p>Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study<\/p>\n<p>https:\/\/doi.org\/10.1007\/s00705-021-04956-9<\/p>\n<p class=\"\">NCT04351295-This was a multicenter randomized controlled study including 96 patients with COVID- 19 who were randomly assigned into a chloroquine (CQ) group and a favipiravir group. None of the patients in the favipiravir group needed mechanical ventilation (p = 0.129). One patient (2.3%) in the favipiravir group and two patients (4.2%) in the CQ group died (p = 1.00). Favipiravir is a promising drug for COVID-19 that decreases the hospital stay and the need for mechanical ventilation.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study https:\/\/doi.org\/10.1007\/s00705-021-04956-9 NCT04351295-This was a multicenter randomized controlled study including 96 patients with COVID- 19 who were randomly assigned into a chloroquine (CQ) group and a favipiravir group. None of the&hellip; <span class=\"read-more-span\"><a href=\"https:\/\/nclinnovations.org\/covid19monitor\/26-jan-2021-favipiravir-decreases-the-hospital-stay-and-the-need-for-mechanical-ventilation\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;(26 Jan 2021) Favipiravir- decreases the hospital stay and the need for mechanical ventilation&#8221;<\/span> <span class=\"genericon genericon-next\"><\/span><\/a><\/span><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"bgseo_title":"","bgseo_description":"","bgseo_robots_index":"index","bgseo_robots_follow":"follow"},"categories":[6,4,11],"tags":[26],"_links":{"self":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/797"}],"collection":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/comments?post=797"}],"version-history":[{"count":1,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/797\/revisions"}],"predecessor-version":[{"id":798,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/797\/revisions\/798"}],"wp:attachment":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/media?parent=797"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/categories?post=797"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/tags?post=797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}